Provided by Tiger Trade Technology Pte. Ltd.

Amgen

348.77
-4.3900-1.24%
Pre-market: 349.901.13+0.32%07:01 EDT
Volume:2.27M
Turnover:797.23M
Market Cap:187.81B
PE:24.51
High:355.66
Open:355.66
Low:347.80
Close:353.16
52wk High:391.29
52wk Low:261.43
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.64
T/O Rate:0.42%
Dividend:9.66
Dividend Rate:2.77%
EPS(TTM):14.23
EPS(LYR):14.23
ROE:106.10%
ROA:7.93%
PB:21.69
PE(LYR):24.51

Loading ...

Amgen Outlook FY26 Share Repurchases Not to Exceed $3 Bln

THOMSON REUTERS
·
Feb 04

Amgen: Phase 1 Study of Amg 513 Enrolling Adults Living With Obesity

THOMSON REUTERS
·
Feb 04

Amgen Q4 Adj EPS $5.29 VS Ibes Estimate $4.73

THOMSON REUTERS
·
Feb 04

U.S. Earnings Preview: After Market Close Feb. 3

Dow Jones
·
Feb 04

Amgen options imply 3.4% move in share price post-earnings

TIPRANKS
·
Feb 04

BUZZ-PREVIEW: Amgen dips with results due after the bell

Reuters
·
Feb 04

Notable companies reporting after market close

TIPRANKS
·
Feb 04

Obesity Drugmakers and Developers Fall After Rival Novo Nordisk Warns of Steep 2026 Sales Decline

THOMSON REUTERS
·
Feb 04

Structure Therapeutics Down 5.3%, Viking Therapeutics Down 3.3%, Amgen Down 1.4%

THOMSON REUTERS
·
Feb 04

MORNING BID AMERICAS-Deals and delays

Reuters
·
Feb 03

TRADING DAY-Solid data over hard assets

Reuters
·
Feb 03

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Galecto (GLTO), Roche Holding AG (OtherRHHVF) and Amgen (AMGN)

TIPRANKS
·
Feb 02

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 02

Assessing Amgen (AMGN) Valuation After Recent Share Price Momentum And Pipeline Expectations

Simply Wall St.
·
Feb 01

Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities

Simply Wall St.
·
Jan 31

Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Amgen (AMGN) and Indivior (INDV)

TIPRANKS
·
Jan 31

Amgen to Terminate License, Collaboration Agreement With Kyowa Kirin for Rocatinlimab

MT Newswires Live
·
Jan 30

Amgen, Kyowa Kirin Ending Atopic Dermatitis Drug Collaboration

Dow Jones
·
Jan 30

Amgen Inc -Co and Kyowa Kirin Terminate License and Collaboration Agreement - SEC Filing

THOMSON REUTERS
·
Jan 30

Amgen Inc - Enters Termination Agreement With Kyowa Kirin - SEC Filing

THOMSON REUTERS
·
Jan 30